#USA #Washington #Danaher Corporation #quarterly dividend #DHR

Danaher Corporation Declares Regular Quarterly Cash Dividend

On May 5, 2026, Danaher Corporation, a leader in life sciences and diagnostics, made an important announcement regarding its financial returns to shareholders. The company's Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common stock. Shareholders will receive this payment on July 31, 2026, provided they are on record by June 26, 2026.

Danaher has been at the forefront of innovations that aim to enhance human health through its cutting-edge scientific and technological advancements. As a company listed on the New York Stock Exchange (NYSE) under the ticker symbol DHR, Danaher continues to drive its mission to solve complex scientific challenges that healthcare professionals face.

The release of this dividend is a clear indication of Danaher's commitment to returning value to its investors while ensuring it has the resources to continue funding its operations and innovations. The consistent dividend payouts reflect the company’s strong financial position and operational excellence, making it a reliable choice for investors seeking both growth and income.

About Danaher Corporation

Danaher Corporation is recognized as a premier global innovator within the life sciences and diagnostics sectors. The company focuses on leveraging a connected ecosystem of high-performance businesses to expedite scientific discoveries and improve human health. Their commitment to excellence is powered by the Danaher Business System, which emphasizes continuous improvement and innovation.

With approximately 60,000 associates worldwide, Danaher is dedicated to enhancing the quality of life across the globe while building a more sustainable future. The ability to innovate and create powerful solutions in diagnostics and healthcare not only mitigates the complexities involved but also promotes the swift delivery of life-saving therapies to patients in need.

Danaher’s integrated approach helps to address critical challenges within the scientific and medical communities, making the processes of diagnosis and therapy development faster, more accurate, and less expensive. By combining advanced technology with operational efficiency, Danaher is uniquely positioned to make a lasting impact in the industry.

The dividend announcement marks a significant moment for investors as they can expect to receive returns on their investment while supporting a company that is at the leading edge of scientific advancements. Those interested can visit Danaher's website for more information about their initiatives and corporate strategy.

In conclusion, as Danaher prepares to distribute its quarterly dividend, it reinforces its dedication to shareholders and highlights its significant role in the advancement of healthcare solutions. Investing in Danaher not only means participating in potential financial gains but also contributing to essential developments that enhance the quality of human life.

—END—

For further inquiries, investors are encouraged to follow the investor relations section on Danaher’s corporate site for updates and more detailed information about their financial performance and future prospects.